Abstract:Background: Estrogen deficiency causes mitochondrial defects that precede pathological changes related to Alzheimer's disease (AD) in the mouse model of postmenopause. The aim of this study was to investigate in such a mouse model whether and how estrogen receptor beta (ER beta) was involved in prevention of mitochondrial damage and protection of neurons in the hippocampus.Methods: A mouse model of postmenopausal AD was created by ovariectomizing female 3xTg-AD mice, some of which were subcutaneously injected for six weeks with the non-steroidal ER beta agonist diarylpropionitrile. ER beta expression in female C57BL/6J mice was knocked down using shRNA interference. The different groups of animals were compared in terms of cognitive function using the Y-maze test, new object recognition test, and Morris water maze test, expression of numerous proteins related to mitochondrial biogenesis, mitophagy, apoptosis, and mitochondrial membrane potential, as well as deposition of amyloid beta and neurofibrillary tangles. To complement these in vivo studies, we probed the effects of diarylpropionitrile on ER beta expression, apoptosis, and mitochondrial homeostasis in primary rat hippocampal neurons treated with amyloid beta.Results: ER beta knockdown in C57BL/6J mice produced cognitive impairment, reduced mitochondrial biogenesis by downregulating PGC-1 alpha, NRF1, mtTFA, and TOM20, and decreased mitophagy by downregulating Pink1, Parkin, and LC3B while upregulating PARIS and p62. ER beta knockdown promoted neuronal apoptosis by upregulating Cleaved-Caspase 9, Cleaved-Caspase 3, and Bax, while downregulating Bcl2 in hippocampus. Diarylpropionitrile mitigated cognitive decline in ovariectomized 3xTg-AD mice, which was associated with downregulation of BACE1, reduction of A beta deposition, neurofibrillary tangles, and tau hyperphosphorylation, and upregulation of ER beta, increases in mitochondrial biogenesis and mitophagy, and decreases in apoptosis. The effects of diary-lpropionitrile in mice were recapitulated in A beta-injured primary rat hippocampal neurons.Conclusions: ER beta activation can support learning and memory and alleviate AD symptoms in the postmenopausal AD model, which may involve regulation of neuronal mitochondrial biogenesis and mitophagy via NRF1/PGC-1 alpha. This study supports further research on ER beta as a therapeutic target for postmenopausal women with AD.

Activation of ERα And/or ERβ Ameliorates Cognitive Impairment and Apoptosis in Streptozotocin-Induced Diabetic Mice

ERα And/or ERβ Activation Ameliorates Cognitive Impairment, Neurogenesis and Apoptosis in Type 2 Diabetes Mellitus Mice

Endoplasmic Reticulum Stress/autophagy Pathway is Involved in Diabetes-Induced Neuronal Apoptosis and Cognitive Decline in Mice.

Estrogen Receptor Β Exerts Neuroprotective Effects by Fine-Tuning Mitochondrial Homeostasis Through NRF1/PGC-1α

Activating glucocorticoid receptor-ERK signaling pathway contributes to ginsenoside Rg1 protection against β-amyloid peptide-induced human endothelial cells apoptosis.

Erythropoietin Ameliorates Cognitive Deficits by Improving Hippocampal and Synaptic Damage in Streptozotocin-Induced Diabetic Mice.

17SS-Estradiol Antagonizes the Down-Regulation of ERα/NOS-3 Signaling in Vascular Endothelial Dysfunction of Female Diabetic Rats.

Carnosine-based reversal of diabetes-associated cognitive decline via activation of the Akt/mTOR pathway and modulation of autophagy in a rat model of type 2 diabetes mellitus

PPARγ agonist pioglitazone reverses memory impairment and biochemical changes in a mouse model of type 2 diabetes mellitus.

Inhibition of soluble epoxide hydrolase (sEH) protects hippocampal neurons and reduces cognitive decline in type 2 diabetic mice

Resolvin E1 ameliorates diabetes‐related cognitive impairment via ChemR23

Neuroprotective Effects of Novel Compound Tozan on Cognition, Neurogenesis and Apoptosis in Diabetes

ChemR23 signaling ameliorates cognitive impairments in diabetic mice via dampening oxidative stress and NLRP3 inflammasome activation

Involvement of Paired Immunoglobulin-like Receptor B in Diabetes-Associated Cognitive Dysfunction Through Modulation of Axon Outgrowth and Dendritic Remodeling

Pioglitazone Ameliorates Memory Deficits In Streptozotocin-Induced Diabetic Mice By Reducing Brain Beta-Amyloid Through Ppar Gamma Activation

PPARγ agonists regulate bidirectional transport of amyloid-β across the blood-brain barrier and hippocampus plasticity in db/db mice.

Sigma-1 Receptor as a Protective Factor for Diabetes-Associated Cognitive Dysfunction via Regulating Astrocytic Endoplasmic Reticulum-Mitochondrion Contact and Endoplasmic Reticulum Stress

Teneligliptin alleviates diabetes-related cognitive impairment by inhibiting the endoplasmic reticulum (ER) stress and NLRP3 inflammasome in mice

Danggui-Shaoyao-San improves cognitive impairment through inhibiting O-GlcNAc-modification of estrogen α receptor in female db/db mice

Erythropoietin ameliorates diabetes-associated cognitive dysfunction in vitro and in vivo

Inhibition of ANGPTL8 protects against diabetes-associated cognitive dysfunction by reducing synaptic loss via the PirB signaling pathway